Cite
MLA Citation
Jason C. Barnett et al.. “Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer.” Cancer, vol. 119, no. 20, 2013, pp. 3653–3661. http://access.bl.uk/ark:/81055/vdc_100070757062.0x00002b